Bioinvent
id:
bioinvent-248-690862
title:
Bioinvent
text:
BioInvent International is a Swedish clinical-stage biotech company that discovers and develops novel and first-in-class immunomodulatory antibodies for cancer therapy. The company’s validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, generatingnew drug candidates to fuel the Company’s own broad clinical development pipeline or for additional licensing and partnering. Currently, the company has five clinical programs
brand slug:
wiki
category slug:
encyclopedia
description:
Swedish clinical-stage biotech company
original url:
https://en.wikipedia.org/wiki/Bioinvent
date created:
date modified:
2023-11-16T20:25:10Z
main entity:
{"identifier":"Q64227952","url":"https://www.wikidata.org/entity/Q64227952"}
image:
fields total:
13
integrity:
14